9,795
Total Claims
$807K
Drug Cost
570
Beneficiaries
$1,417
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-92%
Opioid rate vs peers
0.2% vs 2.6% avg
+33%
Cost per patient vs peers
$1,417 vs $1,068 avg
+65%
Brand preference vs peers
14.8% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
20
Opioid Claims
$197
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
85% generic
Brand: 1,446 claims · $551K
Generic: 8,316 claims · $255K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Glargine,hum.Rec.Anlog | 106 | $64K |
| Dapagliflozin Propanediol | 58 | $49K |
| Empagliflozin | 44 | $47K |
| Dulaglutide | 40 | $45K |
| Levothyroxine Sodium | 387 | $39K |
| Apixaban | 49 | $34K |
| Sitagliptin Phosphate | 29 | $21K |
| Rivaroxaban | 18 | $20K |
| Insulin Lispro | 35 | $19K |
| Semaglutide | 16 | $16K |
| Insulin Glargine,hum.Rec.Anlog | 26 | $13K |
| Atorvastatin Calcium | 531 | $13K |
| Sitagliptin Phos/Metformin Hcl | 25 | $11K |
| Rosuvastatin Calcium | 263 | $9,130 |
| Desonide | 52 | $8,841 |
Prescribing Profile
Patient Profile
74
Avg Age
61%
Female
1.47
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data